Authorizes the administration of the mpox vaccine by a pharmacist or a certified nurse practitioner.

This bill allows pharmacists and certified nurse practitioners in New York to give the mpox vaccine to people. This change aims to make it easier for individuals to access the vaccine, potentially increasing vaccination rates. By expanding who can administer the vaccine, the bill seeks to improve public health responses to mpox.

Supporters of the bill argue that allowing pharmacists and nurse practitioners to administer the mpox vaccine will enhance access and convenience for patients. They believe this will lead to higher vaccination rates and better protection against the disease, particularly in underserved areas. This legislation is seen as a proactive step towards improving public health and safety.

Critics of the bill may express concerns about the qualifications and training of pharmacists and nurse practitioners in administering vaccines. They might argue that such responsibilities should remain with traditional healthcare providers to ensure proper care and oversight. There are fears that this could lead to a decrease in the quality of vaccine administration and patient safety.